Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pala

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Acta Diabetologica|March 18, 2009
Failure to metformin and insulin secretagogue monotherapy: an observational cohort studyLaura Pala, Matteo Monami, Caterina Lamanna, et al.
Diabetes Care|November 21, 2007
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control studyMatteo Monami, Barbara Cresci, Angela Colombini, et al.
Journal of Nutrition and Metabolism|August 27, 2011
Adipokines as possible new predictors of cardiovascular diseases: a case control studyLaura Pala, Matteo Monami, Silvia Ciani, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2019
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trialFabio Conforti, Laura Pala, Eleonora Pagan, et al.
Therapeutic Advances in Medical Oncology|December 4, 2020
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centersMaristella Saponara, Laura Pala, Fabio Conforti, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2026
"Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?"Fabio Conforti, Isabella Sala, Laura Pala, et al.
Scientific Reports|April 20, 2021
Exogenous sex hormones, menstrual and reproductive history, and risk of non-melanoma skin cancer among women: a systematic literature review and meta-analysisSaverio Caini, Simone Pietro De Angelis, Federica Corso, et al.
Biochemical and Biophysical Research Communications|September 27, 2003
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cellsLaura Pala, Edoardo Mannucci, Anna Pezzatini, et al.
International Journal of Cancer|June 3, 2016
Prognostic significance of hematological profiles in melanoma patientsSara Gandini, Pier Francesco Ferrucci, Edoardo Botteri, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature ReviewNunzio Digiacomo, Tommaso De Pas, Giovanna Rossi, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Acta Diabetologica|March 18, 2009
Failure to metformin and insulin secretagogue monotherapy: an observational cohort studyLaura Pala, Matteo Monami, Caterina Lamanna, et al.
Diabetes Care|November 21, 2007
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control studyMatteo Monami, Barbara Cresci, Angela Colombini, et al.
Journal of Nutrition and Metabolism|August 27, 2011
Adipokines as possible new predictors of cardiovascular diseases: a case control studyLaura Pala, Matteo Monami, Silvia Ciani, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2019
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trialFabio Conforti, Laura Pala, Eleonora Pagan, et al.
Therapeutic Advances in Medical Oncology|December 4, 2020
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centersMaristella Saponara, Laura Pala, Fabio Conforti, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2026
"Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?"Fabio Conforti, Isabella Sala, Laura Pala, et al.
Scientific Reports|April 20, 2021
Exogenous sex hormones, menstrual and reproductive history, and risk of non-melanoma skin cancer among women: a systematic literature review and meta-analysisSaverio Caini, Simone Pietro De Angelis, Federica Corso, et al.
Biochemical and Biophysical Research Communications|September 27, 2003
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cellsLaura Pala, Edoardo Mannucci, Anna Pezzatini, et al.
International Journal of Cancer|June 3, 2016
Prognostic significance of hematological profiles in melanoma patientsSara Gandini, Pier Francesco Ferrucci, Edoardo Botteri, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature ReviewNunzio Digiacomo, Tommaso De Pas, Giovanna Rossi, et al.
Pageof 13